Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $629.7400 (0.99%) ($629.7400 - $629.7400) on Mon. Aug. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.31% (three month average) | RSI | 75 | Latest Price | $629.7400(0.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 3.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(37%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.655% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) USO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.655% (StdDev 1.31%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $616.15(2.21%) | 10 Day Moving Average | $608.26(3.53%) | 20 Day Moving Average | $595.74(5.71%) | To recent high | 0% | To recent low | 27.1% | Market Cap | $66.77b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |